ecteinascidin 743 has been researched along with Abnormalities, Autosome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonatto, D; de Gramont, A; Escargueil, AE; Henriques, JA; Larsen, AK; Poindessous, V; Sarasin, A; Soares, DG | 1 |
| Almond, M; Beggs, A; Desai, A; Ford, S; Taniere, P; Tyler, R; Wanigasooriya, K | 1 |
1 review(s) available for ecteinascidin 743 and Abnormalities, Autosome
| Article | Year |
|---|---|
A review of retroperitoneal liposarcoma genomics.
Topics: Animals; Antineoplastic Agents, Alkylating; Chromosome Aberrations; Genomics; Humans; Liposarcoma; Oncogene Proteins, Fusion; Phosphatidylinositol 3-Kinases; Retroperitoneal Neoplasms; Trabectedin | 2020 |
1 other study(ies) available for ecteinascidin 743 and Abnormalities, Autosome
| Article | Year |
|---|---|
Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743.
Topics: Antineoplastic Agents, Alkylating; Cell Cycle; Chromosome Aberrations; Dioxoles; DNA Breaks, Double-Stranded; DNA Repair; DNA Replication; DNA-Binding Proteins; Dose-Response Relationship, Drug; HeLa Cells; Humans; Recombination, Genetic; Tetrahydroisoquinolines; Trabectedin | 2007 |